Pacira Pharmaceuticals (PCRX) Posts Q3 Loss of 30c/Share

October 31, 2013 6:37 AM

Pacira Pharmaceuticals (NASDAQ: PCRX) reported Q3 EPS of ($0.30), $0.05 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found